Lipids in endothelial-to-mesenchymal transition.

Authors

Christina K Tripsas, Abigail Y Tsai, Jeffrey J Hsu

Published in

Current opinion in lipidology. Aug 13, 2026. Epub Aug 13, 2026.

Abstract

Endothelial-to-mesenchymal transition (EndMT) has been implicated in the development of cardiovascular disease, including atherosclerosis. EndMT is a complex continuum with multiple involved pathways, each with different pathophysiologic implications depending on the driving regulators.
In this brief review, we will focus on the latest studies that have helped elucidate the role of lipids and related factors in the initiation of EndMT in the setting of atherosclerosis, with particular attention to atherosclerotic plaque stability and sex specific differences of disease.
We explore potential therapeutic strategies, including the impact that lipid modulation has on EndMT and the effects of EndMT-specific approaches on lipid deposition. Overall, this will inform future areas of research on EndMT modulation.

PMID:
42592967
Bibliographic data and abstract were imported from PubMed on 13 Aug 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.